Speaker illustration

Mr Daniel Ritter

Charite University Hospital, Berlin (Germany)

The LXR-agonist AZ876 attenuates cardiac damage in an isoproterenol induced HFpEF-like cardiomyopathy model

Event: Heart Failure 2019

Topic: Cardiovascular Pharmacotherapy

Session: Basic Science and Translational

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb